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Ehrlich described the presence of rich magenta 
eosin-staining granules that characterize eosin-
ophils over 130 yr ago (Erlich, 1879). Yet, the 
precise roles of eosinophils in health and disease 
remain to be fully de!ned (Rosenberg et al., 
2013). Eosinophils have been identi!ed in tissues 
of lower vertebrates and eosinophil-like cells in 
some invertebrates. Thus, eosinophils evolved 
before adaptive T and B cell immunity emerged 
(McGarry, 2013). Eosinophils may have evolved 
from phagocytic cells in primitive invertebrates 
when digestion and immunity became specialized 
functions (Lenzi et al., 1997). In this regard, the 
intestine is one of few immune sites that na-
tively houses an abundance of eosinophils. The 
presence of eosinophils in the healthy gut has 
long been overlooked (Mowat and Bain, 2010) 
and most research on intestinal myeloid cells has 
rather focused on DCs and macrophages. Thus, 
the function of eosinophils in the healthy gut 
is unclear.
Most work on eosinophils has concentrated 
on their role during Th2 responses, in particu-
lar helminth infections and allergic responses. 
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Eosinophils natively inhabit the small intestine, but a functional role for them there has 
remained elusive. Here, we show that eosinophil-de!cient mice were protected from induc-
tion of Th2-mediated peanut food allergy and anaphylaxis, and Th2 priming was restored 
by reconstitution with il4+/+ or il4/ eosinophils. Eosinophils controlled CD103+ dendritic 
cell (DC) activation and migration from the intestine to draining lymph nodes, events 
necessary for Th2 priming. Eosinophil activation in vitro and in vivo led to degranulation of 
eosinophil peroxidase, a granule protein whose enzymatic activity promoted DC activation 
in mice and humans in vitro, and intestinal and extraintestinal mouse DC activation and 
mobilization to lymph nodes in vivo. Further, eosinophil peroxidase enhanced responses to 
ovalbumin seen after immunization. Thus, eosinophils can be critical contributors to the 
intestinal immune system, and granule-mediated shaping of DC responses can promote both 
intestinal and extraintestinal adaptive immunity.
© 2014 Chu et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the &rst six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ 
by-nc-sa/3.0/).
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sucient as an adjuvant to promote extraintestinal adaptive 
immunity. Collectively, these data identify a critical in vivo role 
for indigenous eosinophils in intestinal immunity, and reveals 
the potential for eosinophil granule-mediated shaping of DC 
responses in promoting adaptive immunity.
RESULTS
De nition of indigenous eosinophils  
along the intestinal tract
Eosinophils along the intestinal tract were histologically quan-
ti!ed in 1999 (Mishra et al., 1999), and Carlens et al. (2009) 
recently established a sensitive "ow cytometric method to evalu-
ate intestinal eosinophils. Here, we took advantage of "ow cy-
tometry’s capability for precise quantitation and multiparameter 
analysis to better de!ne eosinophils along the intestinal tract. 
Eosinophils were most prevalent within the SI, ranging from 
Y15–25% of all lamina propria (LP) leukocytes in the duo-
denum, Y15–35% in the jejunum, and Y5–15% in the ileum 
(Fig. 1 A). The frequency of eosinophils was lower in the large 
intestine (LI), Y3–5% eosinophils in the cecum, Y7% in the 
colon, and <1% in the rectum (Fig. 1 A). Quantifying eosin-
ophil numbers revealed that they decreased along the length 
of the intestinal tract (Fig. 1 A), potentially suggesting nega-
tive regulation by the microbiota. Phenotypically, although 
both SI and LI eosinophils were Siglec-F+, CD11b+, CD44+, 
CD103, and Y30% Ly6G+, SI and LI eosinophils also dis-
played distinct cell surface phenotypes (Fig. 1 B). More SI eosin-
ophils expressed CD11c, and at higher levels, than LI eosinophils. 
As well, a greater proportion of SI eosinophils expressed ST2 
(IL-33 receptor), CD69, and Ly6C, compared with LI eosino-
phils. Therefore, di#erent compartments of the intestine harbor 
di#erent proportions, numbers and phenotypes of eosinophils 
at baseline. Given the prominence of eosinophils in the SI, 
we next sought to evaluate the impact of eosinophil ablation 
on SI function and immunity.
Indigenous enteric eosinophils promote induction  
of Th2 immunity in vivo independently  
of their ability to produce IL-4
$dblGATA1 mice (Yu et al., 2002; Humbles et al., 2004; 
Fattouh et al., 2011), lack a high-anity GATA-binding site 
in the GATA-1 promoter, resulting in strong, but submaximal 
GATA-1 promoter activity and, ultimately, complete ablation 
of the eosinophil lineage (Yu et al., 2002). Other GATA-1–
dependent lineages, namely erythrocytes, megakaryocytes and 
mast cells, are not a#ected as their lineages do not require max-
imal GATA-1 promoter activity. A recent publication suggested 
that $dblGATA1 mice may have slightly reduced basophils 
(Nei et al., 2013).
Intragastric (i.g.) immunization to the common food aller-
gen peanut (PN) with the classical oral Th2-inducing adjuvant 
cholera toxin (CT) induces basophil-independent, OX40L- 
and IL-4–dependent SI Th2 priming, such that subsequent al-
lergen challenge elicits systemic anaphylaxis (Chu et al., 2013) 
similar to human peanut allergy (Li et al., 2000; Leung et al., 
2003; Vadas et al., 2008; Arias et al., 2009, 2011). Whereas WT 
In this regard, eosinophil granulocytes are classically thought 
of as specialized e#ector cells recruited from the blood and 
bone marrow to tissues during adaptive Th2 responses. Thus, 
consistently other than the intestine, most healthy tissues are 
devoid of eosinophils (Barnes, 2004; Rosenberg et al., 2013). 
Once in the tissue, recruited eosinophils are activated, produce 
several cytokines, and release characteristic cationic granules 
such as eosinophil peroxidase (EPO) in a process termed de-
granulation. Eosinophils have been ascribed both bene!cial and 
harmful functions. For example, there is evidence of eosino-
phil attachment to helminths and subsequent degranulation, 
and cytotoxicity toward helminths. However, an indispens-
able role for eosinophils in host defense against helminths re-
mains controversial (Cadman and Lawrence, 2010; Rosenberg 
et al., 2013). With respect to allergic disease, eosinophils are 
thought to play a pathogenic in"ammatory role in diseases such 
as allergic asthma, atopic dermatitis, or food allergy. In response 
to helminths or allergens, Th2 responses in the gastrointesti-
nal (GI) tract, and elsewhere, are characterized by the late in-
"ux of eosinophils into the tissue to mediate in"ammation. 
However, a role for the abundant native GI eosinophil popu-
lation has remained enigmatic (Drury, 1915; Duran-Jorda, 1947; 
Mowat and Bain, 2010).
The small intestine (SI) plays a vital role in the digestion 
and absorption of macronutrients. The immune system must 
recognize food antigens as innocuous and, hence, develop 
tolerance. Extensive work has shown this process to be medi-
ated by oral antigen uptake by CD103+ DCs, which migrate 
to the draining mesenteric LN (MLN) in a CCR7-dependent 
manner to prime antigen-speci!c naive T cells to di#erenti-
ate into T regulatory cells (Pabst and Mowat, 2012). How-
ever, a subversion of oral tolerance leads to aberrant immune 
responses that result in the development of diseases such as food 
allergies. These are characterized by an adaptive Th2 immune 
response that results in IgE-mediated allergic reactions, in-
cluding a life-threatening systemic reaction termed anaphy-
laxis (Burks, 2008; Berin and Sampson, 2013). Compared 
with other known classes of adaptive immune responses, the 
innate mechanisms that drive Th2 induction are much less 
clear (Paul and Zhu, 2010; Pulendran et al., 2010). Indeed, 
the APCs involved, their activation conditions, and T cell po-
larization factors such as the source of the initial IL-4 for Th2 
cell priming remain unclear.
In stark contrast with the classical notion that eosinophils 
participate in immune responses as terminal e#ector leuko-
cytes whose production, migration and activation is under the 
control of adaptive Th2 immunity, we report just the opposite 
process. Here, we found a crucial role for indigenous SI eo-
sinophils in the initiation of Th2 immunity, with critical im-
portance to the development of peanut food allergy. Eosinophil 
activation during intestinal Th2 priming results in the release 
of EPO that controls CD103+ DC activation and CCR7-
dependent migration to the MLN, where DCs then promote 
Th2 responses. We further show that EPO-mediated DC ac-
tivation is functional in both mice and humans, is mediated 
by EPO’s peroxidase enzymatic activity, and that EPO is also 
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possibility that eosinophils were required during SI priming 
to provide IL-4 to promote Th2 di!erentiation. However, 
mixed bone marrow chimeras showed that reconstitution of 
the eosinophil compartment (Fig. 2 C) with IL-4–decient 
eosinophils fully restored Th2 priming to i.g. PN+CT. This 
was borne out by full restoration of antigen-specic IgE pro-
duction, clinical anaphylaxis, and cytokine production (Fig. 2 B). 
Thus, normally resident enteric eosinophils are critical to ini-
tiate SI Th2 immunity in vivo, independent of their ability to 
produce IL-4.
Conventional parameters of intestinal and adaptive 
immunity are intact in eosinophil-de!cient mice
A series of control experiments revealed that eosinophil de-
ciency did not impair conventional parameters of intestinal 
and adaptive immunity, including Peyer’s patch organogenesis 
(Fig. 3 A), intestinal IgA levels (Fig. 3 B), macronutrient up-
take (Fig. 3 C), antigen-specic IgE production in response 
to intraperitoneal immunization, or oral tolerance induction 
(Fig. 3 D). These data show that eosinophil-decient mice are 
not inherently defective in basal intestinal immunity and mac-
ronutrient absorption, nor are they defective in their capability 
to elicit parenteral adaptive Th2 immunity and IgE responses, 
as well as, under basal conditions, to induce CD103+ DC, 
CCR7, and T regulatory cell–dependent oral tolerogenic im-
munity (Pabst and Mowat, 2012). Consistent with reports of 
intact Th2 priming to parenteral immunization in eosinophil-
decient mice (Humbles et al., 2004; Swartz et al., 2006; Knott 
et al., 2007; Fattouh et al., 2011; Svensson et al., 2011), we also 
found that the requirement for eosinophils in initiating Th2 
adaptive immunity was site-dependent as immunization via 
the peritoneum, skin, or rectum, tissues with little to no eo-
sinophils at baseline, resulted in robust Th2 priming (Fig. 3, 
E–G). These data comprehensively show that the immuno-
logical machinery to initiate Th2 responses is intact in eosino-
phil-decient mice. They also show that eosinophils are not 
required to induce anaphylaxis, per se. Thus, eosinophils are 
required for SI Th2 priming, but not baseline intestinal im-
munity or parenteral Th2 priming.
CD11c+ cells are required for intestinal Th2 priming
Aside from being a potential source of IL-4, there is also evi-
dence that granulocytes such as basophils may supplant DCs 
in their requirement as APCs to launch Th2 immune responses 
(Perrigoue et al., 2009; Sokol et al., 2009; Akuthota et al., 2010) 
and eosinophils have been recognized as potential APCs under 
certain conditions (Shi et al., 2000; Akuthota et al., 2010). CD11c-
diphtheria toxin receptor (DTR) transgenic mice are com-
monly used to probe the function of DCs in a given process 
through selective depletion of CD11c+ cells. However, the use 
of CD11c-targeted strategies (e.g., DTR, GFP/YFP-reporters, 
or MACS) to analyze the intestinal immune system is po-
tentially complicated by non-DC CD11c+ populations such 
as GI eosinophils (Carlens et al., 2009; Fig. 1 B). Thus, to 
clarify whether the CD11c-DTR transgenic system depleted 
SI eosinophils, DCs, or both, we generated CD11c-DTR 
mice mounted robust antigen-specic IgE, IgG1, and Th2 
cytokine responses and, clinically, anaphylactic hypothermia 
and hemoconcentration, $dblGATA1 mice did not (Fig. 2 A). 
This defect was corrected by adoptive transfer of eosinophils 
into $dblGATA1 mice (Fig. 2, A and C). Thus, eosinophils were 
required for SI Th2 priming.
Eosinophils are known to be IL-4 competent, including 
in the SI-draining MLN, (Svensson et al., 2011), raising the 
Figure 1. Characterization of eosinophils along the intestinal 
tract. (A, left) Proportion of eosinophils of total LP leukocytes or (right) 
absolute cell number. (B) Phenotypic characterization of eosinophils along 
the intestinal tract. Mean ± SD, n = 6–8, with each sample being pooled 
from 3–4 mice from 4 experiments. D, duodenum; J, jejunum; I, ileum;  
Ce, cecum; Col, colon; R, rectum.
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critical contribution of CD11c+ DCs and eosinophils to ini-
tiating intestinal Th2 priming.
MLN CD103+ DCs, not eosinophils, act as APCs  
during Th2 priming to oral antigen
Adaptive immunity is primed in the draining LNs, where naive 
T cells interact with APCs that have migrated from periph-
eral sites carrying antigen and are equipped with a particular 
package of immunological instructions (Ritz et al., 2002). Thus, 
we further evaluated whether eosinophils or DCs acted as APCs 
by migrating from the SI to the MLN to activate CD4+ T cells. 
CD103+ intestinal migratory DCs are elicited from the SI LP 
after parenteral LPS i.p. administration (Turnbull et al., 2005; 
transgenic → WT BM chimeras, which allow for the depletion 
of CD11c+ cells with repeated injection of DT. Importantly, 
such chimeras treated with DT lacked SI DCs but not CD11c+ 
eosinophils (Fig. 4, A and B), and this was associated with 
Y10–100-fold higher expression of CD11c (and therefore 
likely the DTR transgene) by DCs (Fig. 4 C). Depletion of 
DCs throughout sensitization protected CD11c-DTR → WT 
chimeras from i.g. PN+CT sensitization and anaphylaxis (Fig. 4, 
D–F) as indicated by a lack of antigen-speci!c IgG1 and IgE, 
IL-4 production, and clinical anaphylactic hypothermia and he-
moconcentration. Altogether, these data show that this CD11c-
DTR system can be used to selectively deplete intestinal DCs 
and not CD11c+ SI eosinophils. These also show a di"erential 
Figure 2. Eosinophils are required for 
induction of Th2 immunity to oral antigen. 
WT, $dblGATA1 (GATA), $dblGATA1 mice that 
received eosinophils weekly (GATA+Eos), or 
mixed BM chimeras were kept naive or ad-
ministered PN+CT i.g. weekly for 4 wk. BM 
chimeras were generated by mixing 80%  
WT or $dblGATA1 BM with 20% il4/ BM, 
resulting in mice with il4+/+ or il4/ eosino-
phil compartments, respectively. (A and B, top 
left) Serum PN-speci!c (PN-) IgG1 and PN-IgE 
at week 5. (A and B, top right) Clinical ana-
phylaxis assessment of hypothermia and vas-
cular leakage after i.p. challenge at week 5.  
(A and B, bottom) Th2 cytokine production 
from PN-stimulated splenocytes. (C) SI LP 
eosinophils in WT, eosinophil-de!cient, and 
eosinophil-reconstituted mice. Mean ± SEM,  
n = 3–12 from 3–5 experiments. *, P < 0.05 
versus WT.
JEM Vol. 211, No. 8 
Article
1661
to oral antigen is unclear, especially given reports that mice 
de!cient in CCR7 signaling mount augmented Th2, IgE, and 
in"ammatory responses in various systems (Grinnan et al., 2006; 
Kawakami et al., 2012; Moschovakis et al., 2012). We found 
that CCR7 controlled homing of CD103+ DCs, but not eosin-
ophils, to the MLN and that this was required to drive Th2 re-
sponses to i.g. PN+CT (Fig. 5, E and F). Likewise, IRF8 
(R249C) mutant mice, which are de!cient in the SI CD103+ 
DC subset because of a block in di#erentiation (Edelson et al., 
2010), were sucient in eosinophils (Fig. 5 E) and protected 
from allergic sensitization (Fig. 5 F). These data illustrate a dif-
ferential contribution of eosinophils and DCs to i.g. prim-
ing, whereby antigen-carrying CD103+ DCs are elicited from 
the SI to the MLN in a CCR7-dependent manner and these 
Schulz et al., 2009), and we used this as a positive control in 
our experiments. In response to PN+CT, CD103+ DCs de-
creased in the SI LP (Fig. 5 A), up-regulated CCR7 (Fig. 5 B), 
and accumulated within the MLN (Fig. 5 C), suggesting DC 
migration. Although CD103+ DCs increased within the MLN, 
eosinophils did not (Fig. 5 C). Similarly, MLN DCs, but not 
eosinophils, expressed MHC II, CCR7, and the co-stimulatory 
molecule CD86 (Fig. 5 D). These data suggest that DCs, not 
eosinophils, are the primary migratory APCs in this system.
Under basal conditions, SI CD103+ DCs preferentially 
capture ingested food antigens and then home to the draining 
MLN in a CCR7-dependent fashion to induce oral tolerance 
and T regulatory cells (Worbs et al., 2006; Schulz et al., 2009). 
Whether similar mechanisms take place during Th2 priming 
Figure 3. Conventional features of intestinal and adaptive immunity are intact in the absence of eosinophils. (A) Median number of 
Peyer’s patches with individual data shown. (B) Mean intestinal wash IgA with individual data shown. (C) i.g. glucose challenge and blood glucose 
over time. (D) Serum OVA-specific IgE at day 28 from mice i.g. fed OVA or PBS daily from day 0 to 5 before i.p. immunization on day 7 and 14 with 
OVA adsorbed to aluminum hydroxide. (E–G) WT or $dblGATA1 (GATA) mice were kept naive or administered PN+CT (E) s.c., (F) p.r., or (G) i.p. 
weekly for 4 wk. (E–G, left) Serum PN-specific (PN-) IgG1 and PN-IgE at week 5. (E–G, middle) Clinical anaphylaxis assessment of hypothermia and 
vascular leakage after i.p. challenge at week 5. (E–G, right) Th2 cytokine production from PN-stimulated splenocytes. Mean ± SEM, n = 3–12 from 
2–3 experiments. All WT versus GATA comparisons in this figure were not statistically different (ns).
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in LP eosinophils in vivo, including the development of cyto-
plasmic protrusions and cell membrane ru!ing (Fig. 6 E, top 
row), marked decreases in granule density (Fig. 6 E, top row) 
and the development of degranulation chambers, a sign of exo-
cytosis (Fig. 6 E, top right). We also observed membrane-bound 
granules and semidissolved granules amid extracellular cell de-
bris (Fig. 6 E, bottom left). Together, these data illustrate that 
Th2 priming with PN+CT induces eosinophil degranulation 
by means of both active granule release and eosinophil cytoly-
sis (Fig. 6 E). Notably, several granules lost their electron-lucent 
matrix (Fig. 6 E, bottom right), which contains the eosinophil-
speci"c granule protein, EPO. To test if degranulation could 
result from direct encounter with allergen, eosinophils were 
activated in vitro with lyso-platelet–activating factor (L-PAF) 
as a positive control (Dyer et al., 2010), or PN+CT. Similar 
to L-PAF, PN+CT induced release of EPO (Fig. 6 F). Thus, 
eosinophils control CD103+ DC migration to the MLN in 
response to i.g. PN+CT, and this is associated with degranula-
tion of EPO in vitro and in vivo.
EPO activates mouse and human DCs
EPO is a peroxidase enzyme that oxidizes substrates through 
catalysis of hydrogen peroxide (H2O2). EPO-mediated oxi-
dation of proteins generates 3-nitrotyrosine (3-NT; Duguet 
et al., 2001). As expected (Ain et al., 2002), recombinant EPO 
oxidative activity is abolished upon heat-induced denatur-
ation, direct enzyme inhibition by resorcinol, or if H2O2 sub-
strate is depleted with exogenous catalase (Fig. 7 A).
To test if EPO could directly activate mouse DCs, we gen-
erated BMDCs and incubated them with media, increasing 
migratory DCs act as a critically required APC to initiate adap-
tive Th2 immunity.
Eosinophil control of DC activation and migration  
is associated with degranulation in vitro and in vivo
That ablation of either eosinophils or CD103+ DCs prevented 
the induction of Th2 responses suggested that these two cell 
types acted in series rather than in parallel. The capability to 
induce adaptive immunity by nonoral immunization routes 
(Fig. 3) suggested that the defect in immunizing $dblGATA1 
mice i.g. was upstream of T or B cell activation and di#eren-
tiation. Consistent with this reasoning, we found that eosino-
phils were required for CD103+ DC mobilization to the MLN 
in response to i.g. PN+CT (Fig. 6 A). Although CD103+ DCs 
were comparable in their baseline activation and expression 
of CCR7 and CD86, only CD103+ DCs from WT or eosino-
phil-reconstituted $dblGATA1 mice up-regulated CCR7 and 
CD86 (Fig. 6 A) and emigrated from the LP in response to 
intestinal priming with PN+CT (Fig. 6 B). Likewise, acti-
vated CD103+ DCs accumulated in the MLN of WT, but not 
eosinophil-de"cient mice, and this was corrected with eosin-
ophil reconstitution (Fig. 6 C). The ability to mobilize SI DCs 
was not inherently disabled in eosinophil-de"cient mice be-
cause CD103+ DCs migrated to the MLN in response to i.p. 
LPS (Fig. 6 C).
To better understand how eosinophils control DC activation 
and migration, we undertook ultrastructural analysis of intesti-
nal eosinophils within 24 h after i.g. PN+CT priming. Electron 
microscopy revealed that compared with normal SI eosinophils 
(Fig. 6 D) i.g. PN+CT caused marked morphological changes 
Figure 4. CD11c-DTR → WT chimeras show that DCs are required for induction of Th2 immunity to oral antigen. CD11c-DTR → WT chimeras 
received i.p. PBS or DT 24h before each i.g. PN+CT, weekly, for four weeks. (A and B) Depletion of SI DCs but not eosinophils. (C) Comparison of CD11c MFI ± SD 
between SI eosinophils and CD103+ DCs. (D) Serum PN-specic PN-IgE at week 5. (E) Clinical anaphylaxis assessment of hypothermia and hemoconcentration 
after i.p. challenge at week 5. (F) Th2 cytokine production from PN-stimulated splenocytes. Mean ± SEM unless otherwise stated; n = 5–10 from  
2 experiments. *, P < 0.05 versus (B and F) -DT or (C) DCs. ns, not statistically different.
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Th2 responses through modulation of DC IL-12 production. 
To accomplish this, mouse DCs were conditioned with media, 
EPO, or CT as a positive control (Braun et al., 1999; Chu et al., 
2013) before activation with LPS. Compared with mock con-
ditioning, EPO signi!cantly inhibited DC IL-12p40 pro-
duction (Fig. 7 D). Thus, EPO directly activates mouse DC 
co-stimulatory molecule expression and proin"ammatory 
cytokine production through its enzymatic activity, while also 
suppressing IL-12p40 production.
We next tested if this pathway was conserved in humans 
by incubating EPO with monocyte-derived DCs from 
healthy adult donors. EPO consistently activated human DCs 
concentrations of EPO, or a replication-de!cient vesicular sto-
matitis virus (VSV) as a positive control (Boudreau et al., 2009). 
Compared with media controls, mouse DCs stimulated with 
EPO expressed higher levels of CD80, CD86, CCR7, and 
OX40L (Fig. 7 B), a co-stimulatory molecule that we have pre-
viously shown to be critical for driving intestinal Th2 immu-
nization (Chu et al., 2013; Chu et al., 2014a). This e#ect was 
inhibited by heat-inactivation of EPO or co-incubation of 
EPO with resorcinol (Fig. 7, A and B). Consistent with this, 
DCs activated with EPO secreted high levels of IL-6 (Fig. 7 C) 
and TNF (not depicted), and this was inhibited by resorcinol or 
heat inactivation. We also tested if EPO selectively promoted 
Figure 5. CD103+ DCs are required for induction of Th2 immunity to oral antigen. WT, CCR7 KO, or IRF8(R249C) mice were administered 
PN+CT i.g. for three consecutive days, or weekly for 4 wk. (A) SI DC percentage and number after three consecutive days of PN+CT i.g., or 16 h after 
LPS i.p. (B) SI DC expression of CCR7. (C) DC and eosinophil percentages in MLN in response to PN+CT (D) Expression of MHC II, CCR7, and CD86 on 
DCs but not eosinophils. (E) Migratory DCs and eosinophils in CCR7 KO and IRF8(R249C) mice. (F) Immunological and clinical responses in the absence 
of CD103+ DCs. Mean ± SEM, n = 3–10 from 2 experiments. *, P < 0.05 versus (A) Naive or (F) WT.
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EPO-mediated mobilization and activation  
of DCs is required for intestinal Th2 priming
We next tested if this EPO–DC pathway was important for 
intestinal priming in vivo. In response to i.g. PN+CT, EPO-
decient mice phenocopied $dblGATA1 mice. Indeed, a lack 
of EPO resulted in the inability of DCs to be mobilized from 
the SI LP (Fig. 8, A and B) to the MLN (Fig. 8 C) and become 
activated, including up-regulation of CCR7, CD86, and OX40L 
(Fig. 8 D). As it would then be expected, EPO deciency re-
sulted in a lack of induction of antigen-specic IgE (Fig. 8 E) 
and full protection from anaphylaxis (Fig. 8 F), peritoneal de-
layed-type hypersensitivity eosinophilic in!ammation (Fig. 8 G), 
and Th2 cytokine production (Fig. 8 H).
Similar to eosinophil-decient mice, parenteral immuni-
zation did not rely on EPO for DC mobilization and activa-
tion, IgE or cytokine production, or induction of allergy and 
in a dose-dependent manner, and this was inhibited by heat 
inactivation or resorcinol inhibition (Fig. 7 E). An end-product 
of EPO activity is the nitration of proteins, most readily 
detected as 3-NT (Duguet et al., 2001; Ulrich et al., 2008), 
and we questioned if 3-NT mediated the activation of DCs 
by EPO. However, 3-NT failed to stimulate human DCs 
over media controls (Fig. 7 E), suggesting that EPO activates 
DCs independently of 3-NT generation. Similar to mouse 
DCs, human DCs activated with EPO also secreted high 
levels of IL-6 (Fig. 7 F) and TNF (not depicted). Lastly, we 
evaluated potential toxicity of EPO-mediated activation of 
DCs. Notably, cell viability was not impaired after incuba-
tion of mouse and human DCs with EPO (Fig. 7 G). Thus, 
EPO can be a nontoxic direct activator of multiple DCs pa-
rameters through its oxidant enzyme activity in both mice 
and humans.
Figure 6. Eosinophil control of CD103+ 
DC migration and activation is associated 
with degranulation in vitro and in vivo. 
WT, DdblGATA1 (GATA), or eosinophil-recon-
stituted (GATA+Eos) mice were kept naive or 
received PN+CT i.g. daily for three consecu-
tive days, or i.p. LPS 16 h before analysis.  
(A) Expression of CCR7 and CD86 on SI DCs. 
(B) LP DC cell number. (C) Proportion, num-
ber, and activation status of CD103+ DCs in 
MLN. (D, top and bottom) Normal SI eosino-
phil transmission electron microscopy ultra-
structure, showing bi-lobed nuclei and a 
high density of granules composed of an 
electron-dense core surrounded by an elec-
tron-lucent matrix rich in EPO (arrowhead). 
(E, top left) PN+CT-stimulated intact eosino-
phil with marked membrane protrusions and 
ruf!ing with loss of granule density. (E, top 
right) Formation of degranulation chambers 
(arrowheads). (E, bottom left) Extracellular 
free granules amid apoptotic/necrotic eosino-
phil debris (arrowheads). (E, bottom right) Disso-
lution of eosinophil granule matrix. (F) Puri"ed 
eosinophils were incubated for 24 h with L-PAF 
or increasing amounts of PN+CT and assayed 
for EPO activity. Mean ± SEM, n = 3–8 
from 2–4 experiments. *, P < 0.05 versus 
WT. ns, not statistically different versus WT.
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inammatory cellular responses, including total cells, eosino-
phils, DCs, and Th2 cells (Fig. 10 E). Both IL-5 and IL-13 were 
elevated in the lungs of mice immunized with OVA+EPO 
compared with those immunized with OVA alone (Fig. 10 F). 
Consistent with this, histological analysis of lungs revealed 
greater cellular inammation and goblet cell hypertrophy and 
hyperplasia (Fig. 10 G). These enhanced responses were main-
tained during recall cytokine production, suggesting enhanced 
priming in the OVA+EPO group over those immunized with 
OVA alone. Thus, although EPO is necessary for enteral, but 
not parenteral, immune priming, these data show that EPO is 
su!cient for extraintestinal DC activation and promotion of 
adaptive immunity in vivo.
DISCUSSION
Recruited eosinophil granulocytes are a hallmark of Th2- 
mediated immune responses. However, in some tissue, partic-
ularly in the SI, eosinophils are constitutively present. In contrast 
to the conventional view of eosinophils as e"ector cells during 
anaphylaxis (Fig. 9). Thus, DCs rely on eosinophil cues, at least 
in the form of EPO, to become activated and migrate to the 
MLN to initiate intestinal adaptive immunity in vivo.
EPO promotes extraintestinal DC activation  
and adaptive immunity
Lastly, we evaluated whether EPO-mediated DC activation 
could be functional outside of the intestine in vivo. In response 
to the administration of EPO s.c. or i.p., DCs became acti-
vated and migrated to draining LNs (Fig. 10, A–C), suggesting 
that EPO could promote extraintestinal innate-to-adaptive 
immune activation.
To test if EPO could act as an adjuvant in vivo, we used a 
standard model involving i.p. immunization, followed by recall 
i.n. challenge to induce airway inammation. Compared with 
i.p. OVA alone, i.p. combination OVA with EPO (OVA+ 
EPO) induced enhanced levels of OVA-speci#c IgG1 and IgE 
(Fig. 10 D). Further, when these mice were challenged with 
OVA i.n., OVA+EPO-immunized mice mounted greater 
Figure 7. EPO activates mouse and human DCs. (A) Characterization of recombinant EPO activity and conditions for enzyme inactivation. (B) Mouse 
BMDC activation status and (C) cytokine production was analyzed after incubation with increasing concentrations of EPO with or without resorcinol 
(Res), heat-inactivated EPO (xEPO), or a positive control replication-de!cient vesicular stomatitis virus. (D) BMDCs were conditioned for 16 h with media, 
EPO, or CT as a positive control before stimulation with media or LPS and analysis for IL-12p40 by intracellular cytokine staining. (E) Human monocyte-
derived DC activation status and (F) cytokine production was analyzed after incubation with increasing concentrations of EPO with or without resorcinol, 
xEPO, or 3-nitrotyrosine (3NT). (G) Viability of mouse and human DCs by PI exclusion and "ow cytometry. Mean ± SEM, n = 3–8 from 2–4 experiments for 
mouse DCs; n = 16 from 2–4 experiments for human DCs. *, P < 0.05 vs. media. #, P < 0.05 versus 4 µg/ml EPO.
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this baseline eosinophilia is partially dependent on eotaxin 
(Mishra et al., 1999) and independent of B7-integrin (Artis 
et al., 2000). More recently, Carlens et al. (2009) developed an 
eosinophil-sensitive intestinal isolation and !ow cytometry 
method. They showed that SI eosinophils have a markedly 
longer lifespan compared with circulating eosinophils, and that 
regulation of cell survival rather than constant in!ux of newly 
generated eosinophils likely determines baseline SI eosinophilia 
(Carlens et al., 2009). Although additional factors that regulate 
homeostatic intestinal eosinophilia remain to be determined, 
herein we sought to better dene the number of phenotype 
along the intestinal tract. We found that the SI, particularly the 
duodenum and jejunum, is enriched in eosinophils compared 
with the LI. Further, SI and LI eosinophils di#ered in expres-
sion of ST2, CD69, Ly6C, and CD11c. That CD11c is corre-
lated with eosinophil longevity (Carlens et al., 2009) suggests 
that LI eosinophils may have shorter lives and hence, rely more 
on in!ux from the blood to maintain homeostatic tissue levels. 
This further supports the notion that SI and LI eosinophils 
may di#er phenotypically and functionally. Indeed, priming 
through tissues with little to no baseline eosinophilia, such as 
the skin, peritoneum, or rectum, resulted in unimpaired Th2 
priming in eosinophil decient mice, which is consistent with 
Th2 responses, here we show that intestinal eosinophils play a 
critical role in the initiation of Th2 immunity with direct rel-
evance to the development of food allergy. Eosinophil acti-
vation during intestinal immunization results in the release 
of EPO that triggers CD103+ DC activation and CCR7-
dependent migration to the MLN, where DC CD86 and 
OX40L then control induction of Th2 responses. In support 
of these data, human intestinal eosinophils also degranulate 
during infection with CT-producing Vibrio cholera (Qadri et al., 
2004), patients with food allergy exhibit increased intestinal 
eosinophil activation and degranulation compared to non-
allergic controls (Vandezande et al., 1999; Schwab et al., 2003), 
and in vitro co-cultures of human DCs and eosinophils result in 
enhanced DC activation to CpG-ODN stimulation (Lot and 
Lotze, 2008). Indeed, here, we also show that EPO activates 
mouse and human DCs through its enzymatic activity, and this 
pathway is su$cient for EPO to act as an adjuvant in vivo. Thus, 
eosinophil-granule-DC shaping of adaptive immune responses 
may represent a therapeutic target in food allergy, and may also 
be a useful adjuvant or immunomodulator for other diseases.
The healthy intestinal tract has long been recognized as 
the most abundant site of normally resident eosinophils. His-
tological analyses of genetically decient mice have shown that 
Figure 8. EPO controls CD103+ DC migration, activation, and induction of Th2 immunity in vivo. WT or EPO-decient mice were kept naive or 
(A) administered LPS i.p. 16 h before analysis, or (A–D) PN+CT i.g. daily for 3 d or (E–H) weekly for 4 wk. (A) Proportion and number of CD103+ DCs in SI LP.  
(B) Activation status of SI DCs. (C) Proportion and number of CD103+ DCs in the MLN. (D) CCR7, CD86, and OX40L expression. (E) Serum PN-IgE at week 5. 
(F) Clinical anaphylactic hypothermia and hemoconcentration. (G) Peritoneal eosinophilic inammation 72 h after i.p. challenge. (H) Th2 cytokine produc-
tion. Mean ± SEM, n = 3–8 from 2–3 experiments. *, P < 0.05 versus WT.
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of Th2-cytokine mediated immunity. The defect in intestinal 
immunization of eosinophil-de!cient mice was instead more 
proximal to the level of T or B cell activation as these mice could 
fully mount cellular and humoral Th2 responses to priming 
through the lung (Fattouh et al., 2011), skin, or peritoneum. 
These data highlight novel and essential contributions of in-
digenous eosinophils to shaping adaptive immunity. During 
the review of our article, a study was published that suggests a 
role for eosinophils in regulating B cells, particularly intestinal 
IgA (Chu et al., 2014b). These and our data also raise questions 
as to how eosinophils might regulate commensal microbes and 
vice versa.
Tolerance and immunity are viewed as opposing outcomes 
after intestinal antigen encounter with the immune system 
(Pabst and Mowat, 2012). DCs are also thought to be central 
to this process, with antigen-bearing CD103+ DCs migrating 
in a CCR7-dependent manner to the MLN to induce T reg-
ulatory cells. It is less clear how Th2 responses are induced. 
Indeed, Th2 responses to the intestinal helminth T. muris re-
quire basophils to act as APCs instead of DCs (Perrigoue et al., 
2009). Although we have previously shown that basophils are 
not required for Th2 priming to oral antigen (Chu et al., 2013), 
we questioned the importance of DCs in this system. Indeed, 
although Fahlén-Yrlid et al. (2009) showed that CD11c-DTR–
mediated depletion of CD11c+ cells prevented OVA+CT-
induced IgG and IgA titers, it remained unclear to what extent 
this was due to depletion of DCs or eosinophils and whether 
or not this truly impacted Th2 immunity. Here, we clarify that 
at least this CD11c-DTR system can selectively deplete DCs 
reports of largely intact Th2 responses to the helminths Schis-
tosoma mansoni (Swartz et al., 2006), Nippostrongylus brasiliensis 
(Knott et al., 2007), or Trichuris muris (Svensson et al., 2011) in 
the absence of eosinophils. Nevertheless, it remains to be tested 
whether the eosinophil–DC activation pathway identi!ed here 
might also be operative in other tissues with abundant indige-
nous eosinophil populations, such as the uterus or thymus, or 
those in a pathological (hyper)eosinophilic state.
Aside from their classical cytotoxic/destructive in#amma-
tory functions, eosinophils have more recently been ascribed 
various immunomodulatory and tissue remodeling activities 
(Rosenberg et al., 2013; Wong et al., 2014). Notably, several of 
these reports stem from in vitro work or data on eosinophils 
in!ltrating helminth infected or allergen exposed tissues such 
as the lung, skin, or peritoneum. First, direct APC activity for 
T cell priming has been shown for eosinophils after they were 
Ag-pulsed in vitro, and then placed in co-culture or transferred 
to otherwise naive mice (Shi et al., 2000; Akuthota et al., 2010). 
Second, eosinophils have been shown to express IL-4 (Lacy 
and Moqbel, 2000; Shinkai et al., 2002; Voehringer et al., 2004; 
Svensson et al., 2011), and as the initial source of IL-4 required 
for naive CD4+ T to Th2 di$erentiation remains contentious, 
eosinophils have been speculated to be a potential candidate 
for this. In support of these data, eosinophils have long been 
recognized to localize to the T cell zone of LNs (Litt, 1964). 
Here, we found that intestinal LN eosinophils did not express 
MHC II, CCR7, or CD86 or increase in number under naive 
or immunized conditions in vivo and, further, that selective 
deletion of IL-4 in eosinophils did not impair the induction 
Figure 9. Parenteral immunization bypasses the 
requirement for EPO in DC activation and Th2  
immunity. (A) WT or EPO-de!cient mice received s.c. 
PN+CT or were kept naive, and draining inguinal LNs 
were analyzed 16–18 h later. Mice were immunized s.c. 
or i.p. weekly for 4 wk, or kept naive. (B) PN-IgE at wk 5.  
(C and D) Clinical responses after allergen challenge.  
(E) IL-4 production. Mean ± SEM, n = 3–8 from 2 experi-
ments. ns, not signi!cantly different.
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LN to prime T cells. We found that EPO oxidant enzymatic 
activity induced mouse and human DCs to up-regulate mul-
tiple co-stimulatory molecules, produce cytokines such as 
IL-6, and suppress IL-12p40 expression, without inducing 
toxicity. Although a hallmark end-product of EPO activity 
is production of 3-NT, stimulation of DCs with this failed to 
mimic the e!ects of EPO. Nonetheless, these data fortify the 
notion that DCs may heavily rely upon signals from the micro-
environment, now including eosinophil cues, to initiate spe-
cic classes of adaptive immunity. Consistent with this, we 
found that eosinophil deciency prevented Th2 induction, 
but did not impact T regulatory cell-mediated oral tolerance. 
Thus, the initiation and articulation of adaptive immunity is 
not only determined by direct DC sensing of antigen, but 
over eosinophils, likely due to the 10–100-fold higher expres-
sion of CD11c on DCs and transgenic system setup. We fur-
ther show that ablation of oral tolerance-associated CD103+ 
DCs or CCR7 prevented Th2 immunization. Thus, these data 
identify DCs as being critical for Th2 immunity in this system 
and further illustrate the potential Janus nature of intestinal 
CD103+ DCs as inducers of either tolerance or immunity to 
oral antigen (La!ont et al., 2010).
Granulocyte-DC cooperation has been reported in pa-
pain-induced Th2 responses, with antigen-presenting DCs 
cooperating with IL-4+ basophils during T cell priming (Tang 
et al., 2010). Herein, we identify a di!erent level of granulo-
cyte-DC cooperation: eosinophils and EPO mediate activa-
tion of DCs, and these activated DCs then migrate to the 
Figure 10. EPO promotes extraintestinal DC and adaptive immune activation in vivo. (A–C) WT mice received PBS, EPO, or heat-inactivated EPO 
(xEPO) s.c. or i.p. and 24 h later, respective draining inguinal (ILN) or thoracic (tLN) LNs were analyzed. (D–H) WT mice were immunized with OVA alone 
(OVA) or combination OVA with EPO (OVA+EPO) i.p. on d0 and 14, challenged i.n with OVA on d28-30 and analyzed 24 h later. (D) Serum OVA-speci!c 
IgG1 and IgE. (E) BAL in"ammatory cells identi!ed by total cell count and "ow cytometry. (F) IL-5 in BAL and IL-13 in lung homogenates. (G) HE staining 
of lung sections and PAS staining to identify goblet cells. (H) IL-4 and IL-13 cytokine production from OVA-stimulated splenocytes. Mean ± SEM, n = 3–7 
from 2 experiments. *, P < 0.05 versus (A and B) PBS, (C) xEPO, or (D–H) OVA alone.
JEM Vol. 211, No. 8 
Article
1669
or APC. Fluorescence minus one (FMO) controls were used for gating. Data 
were acquired on an LSR II (BD) and analyzed using FlowJo (Tree Star).
Intestinal Ig measurements. Intestines were !ushed with 5 ml ice cold 
soybean trypsin inhibitor (Sigma-Aldrich) in PBS-EDTA-PMSF, centrifuged 
at 2,000 rpm for 10 min, and supernatants analyzed for total IgA (Hapfelmeier 
et al., 2010).
Glucose uptake. After an overnight fast, 2 g/kg d-glucose was administered 
by oral gavage. Blood glucose was measured at various time points using a 
hand-held glucometer (Accu-CheckActive; Roche).
Oral tolerance. Mice were fed with PBS or 1 mg OVA (Grade V; Sigma-
Aldrich) i.g. daily for days 0–5, and then injected with 200 µg OVA adsorbed 
to 1 mg aluminum hydroxide i.p. on days 7 and 14. Serum was collected on 
day 28 and analyzed for OVA-IgE (Cayman).
Peanut allergy model. 3.75 mg PN (Kraft) with 5 µg CT (List Biologi-
cals) was administered i.g. (Delvo), i.p., p.r., or s.c. weekly for 4 wk, with 
challenge by crude PN extract (CPE; Greer) 1 wk later. Serum was col-
lected 24 h before challenge and analyzed for PN-speci$c Igs (Chu et al., 
2013). Temperature was assessed by rectal probe, and hematocrit by centri-
fuging anticoagulated blood at 40 min after challenge. Peritoneal lavage 
(PL) was performed with PBS-EDTA. Total cells were counted using Turks 
and hemocytometer. Peritoneal eosinophils were quanti$ed using !ow cytom-
etry as F4/80lo, Siglec-F+ cells.
Adoptive transfer. Spleen and PL from IL-5Tg mice were labeled with bi-
otin-labeled antibodies against CD3, CD19, Thy1.2, B220, CD11c, MHC II, 
F4/80, c-Kit, TER-119, and >90% pure eosinophils isolated using antibiotin 
microbeads and LS MACS columns (Miltenyi Biotec) before 5 × 107 eosino-
phils were transferred i.v. to $dblGATA1 mice 16–24 h before each gavage.
Cytokine production. 800,000 live splenocytes were cultured for 120 h in 
complete RPMI alone or supplemented with 250 µg/ml CPE and cytokines 
in cell-free supernatants were quanti$ed using Luminex (Millipore) or ELISA 
(R&D Systems).
Bone marrow chimeras. Mice irradiated twice with 5.5 Gy (Cs137 source) 
received 5 × 106 T cell depleted BM cells i.v., rested for 8 wk, and then were 
used in experiments. 100 ng DT was injected i.p. 24 h before each gavage for 
CD11c-DTR experiments. For mixed BM chimeras, i.v. injections were 
composed of 80% WT or $dblGATA1 BM mixed with 20% IL-4 KO BM.
LN processing. LNs were triturated between frosted slides in HBSS, washed 
and $ltered (40 µm).
Transmission electron microscopy. Immediately after excision, tissues were 
immersed in $xative consisting of 3% formaldehyde and 1% glutaraldehyde 
in 0.1-M phosphate bu*er (pH 7.2). After the initial $xation, samples were 
post-$xed in 1% osmium tetroxide for 1 h, dehydrated in graded acetone so-
lutions, and embedded in Polybed 812 (Polysciences, Inc.). Ultrathin sections 
(60–80 nm) were cut on an LKB MK III ultratome and routinely contrasted 
with uranyl acetate and lead citrate. The sections were examined using a FEI 
Tecnai Spirit BioTWIN transmission electron microscope (Fei).
EPO assay. With minor modi$cations from previously described EPO as-
says (Humbles et al., 2002; Dyer et al., 2010), eosinophils were isolated as de-
scribed above, and incubated for 24 h with media, L-PAF (Sigma-Aldrich), 
and 1 or 10 µg/ml PN+CT and assayed for EPO activity by oxidation of 
o-phenylenediamine (Sigma-Aldrich), stopped with sulphuric acid and ab-
sorbance measured at 492 nm. Results were normalized to maximal ac-
tivity from Triton-X 100 lysed eosinophils. EPO was heat denatured by 
incubation at 90°C x 15–60 min and inhibited with resorcinol or catalase 
(both Sigma-Aldrich).
also by the demographics and activity of the cells neighbor-
ing those DCs.
We have analyzed the contribution of eosinophils to mul-
tiple parameters of intestinal innate and adaptive immunity and 
have found that normally resident SI eosinophils initiate pri-
mary adaptive immune responses through a pathway conserved 
in mice and humans that is dependent on EPO oxidant enzy-
matic activity. These data identify a role for indigenous eo-
sinophil populations in in!uencing the initiation of adaptive 
immunity, as well as a Th2 induction pathway whereby the 
hallmark e*ector cell type also acts as an incipient early inducer 
of the very same immune cascade. That we identify a molecular 
link between food, eosinophils, DCs and T cell priming, sug-
gests that eosinophil activation in the intestine may represent a 
primitive digestive-immune mechanism that has been coopted 
during evolution to aid in the initiation of adaptive immunity. 
Indeed, DC activation required degranulation of the microbi-
cidal peroxidase EPO, consistent with an innate defense role 
for intestinal eosinophils (Youse$ et al., 2008). While this path-
way is necessary to promote adaptive immunity in the SI, it is 
can be fully instigated extraintestinally. Therefore, the identi$-
cation of a mechanism that shapes adaptive immunity through 
cooperative eosinophil-DC interaction should broadly encour-
age investigation into the role of eosinophils, EPO, or other 
eosinophil products in the (patho)genesis or treatment of im-
mune mediated processes such as chronic in!ammation, allergy, 
autoimmunity, cancer, vaccines and infectious disease.
MATERIALS AND METHODS
Mice. Age-, sex-, vendor-, and strain-matched controls were used in all experi-
ments. $dblGATA1 (C.Cg-Gata1tm6Sho) and CD11c-DTR (B6.FVB-Tg(Itgax- 
DTR/EGFP)57Lan/J; Jung et al., 2002) mice were bred in-house. IL-4 KO 
(BALB/c-Il4tm2Nnt/J), CCR7 KO (B6.129P2(C)-Ccr7tm1Rfor/J), IRF8(R249C; 
BXH2/TyJ), and EPO-de$cient (Duguet et al., 2001; NZW/LacJ) mice were 
purchased from The Jackson Laboratory. IL-5 transgenic (IL-5Tg) mice were 
obtained from Charles River. All procedures were approved by the McMaster 
University Research Ethics Board.
Intestinal cell isolation. Intestines were opened longitudinally, cut into 
2–3 mm pieces and incubated in 1mM DTT (Sigma-Aldrich) in PBS for 
15 min, and then 3 rounds of 15 min in 10% FBS in PBS and 2 mM EDTA 
before digestion in 0.239 mg/ml Collagenase A (Roche) with DNase (Roche) 
for 50–60 min and 40/70% Percoll (GE Healthcare) separation (Carlens 
et al., 2009).
Flow cytometry. In all assays, cells were incubated with anti-FcGRII/IIIb 
before incubation with !uorochrome-conjugated antibodies. Dead cells were 
excluded by propidium iodide (PI) uptake or $xable viability dye eFluor780 
(eBioscience), and gated on singlets. Whole blood was anticoagulated with 
EDTA and lysed with ACK lysis bu*er before staining. Antibodies were ob-
tained from eBioscience, BD, or BioLegend: CD3-FITC or Paci$c Blue; 
CD4-APC, eFluor605, or eFluor650; CD19-PE-Cy5; MHC II-eFluor 650 
or Alexa Fluor 700; F4/80-eFluor 450 or Paci$c Blue; Siglec-F-PE; CD44-
V500 or Alexa 700; B220-eFluor650 or V500; Ly6G-Alexa 700 or APC-Cy7; 
Ly6C-Alexa Fluor 700 or APC-Cy7; ST2-FITC or biotin; CD11b-PerCP-
Cy5.5, Alexa Fluor 488, PE-Cy7, or Alexa Fluor 700; CD11c-APC, PerCP-
Cy5.5, or PE-Cy7; CD69-PE-Cy7; CD45-eFluor605 or APC-eFluor780; 
CD103-APC, Brilliant Violet 421, or biotin; CD80-FITC; CD86-PE-Cy7, 
PerCP-Cy5.5, or eFluor605; OX40L-biotin; CCR7-biotin or APC; Strepta-
vidin-APC, Qdot-800 (Invitrogen), or PE; IL-12p40-PE or APC; and TNF-PE 
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